May 29, 2021
Janssen’s Multiple Sclerosis Treatment Scores European Approval
- /
The European Commission has approved Janssen’s, a unit of Johnson & Johnson Ponvory (ponesimod), to treat adult patients with relapsing multiple sclerosis.…
MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.
May 29, 2021
New vaccine guidance for people living with MS plus the latest information and resources.
- /
- /
Last updated: May 21, 2021 Información disponible en español. Overall Society statement on vaccination Vaccination against COVID-19 is critical for public…
May 29, 2021
Long-term natalizumab treatment is associated with sustained improvements in quality of life in patients with multiple sclerosis
- /
Background Multiple sclerosis (MS) patients experience lower health-related quality of life (HRQoL) than the general population. In clinical trials, natalizumab…
May 29, 2021
Native ancestry is associated with optic neuritis and age of onset in Hispanics with multiple sclerosis
- /
Abstract Background and Objective Hispanics with multiple sclerosis (MS) present younger and more often with optic neuritis (ON) as…
May 29, 2021
MORE ABOUT MS – An Exploration of the MS Journey – presented by CMSC on October 7, 2021 in Orlando, Fl. and by Live Stream
- /
- /
Click image to link to the CMSC registration page for an in-person visit or their livestream Visit our MS…
May 28, 2021
May 30, 2021 – MS WORLD DAY – Tune-in for MS
- /
May 30, 2021 We are not alone: the global multiple sclerosis community connects through the power of music The…
May 28, 2021
Native American ancestry significantly contributes to neuromyelitis optica susceptibility in the admixed Mexican population
- /
- /
Abstract Neuromyelitis Optica (NMO) is an autoimmune disease with a higher prevalence in non-European populations. Because the Mexican population…
May 28, 2021
Mayzent, Zeposia May Lose Ground in Canada, Report Finds
- /
MAY 27, 2021 – BY MARTA FIGUEIREDO PHD Click HERE to Subscribe for the MS Beacon eNewsletter Mayzent (siponimod) and Zeposia (ozanimod), the…
May 25, 2021
A Study Comparing Patient and Clinician Perspectives of Treatments for Multiple Sclerosis via Group Concept Mapping
- /
Barry A Singer,1 Shannon Keith,2 Amy Howerter,3 Helen Doll,3 Timothy Pham,4 Rina Mehta4 1The MS Center for Innovations in Care, Missouri, Baptist Medical Center, St.…
May 25, 2021
Sexual Satisfaction in Fully Ambulatory People with Multiple Sclerosis: Does Disability Matter?
- /
Pawel Dobrakowski 1, Agnieszka Machowska-Majchrzak 1, Beata Labuz-Roszak 2, Ewa Niewiadomska 3, Krystyna Pierzchala 1 Affiliations expand PMID: 33101540 PMCID:…
